Bank of Montreal: Looking At Overvaluation And Q2

Bank of Montreal is trading at 17x P/E, well above its historical 10-12x range, prompting a Hold rating and a $140 CAD/share fair value target. The article questions whether post-Bank of the West integration can sustain U.S.-centric growth and elevated returns, highlighting valuation risk and macro sensitivity. The commentary is likely to pressure sentiment but is unlikely to be a major market-moving catalyst on its own.

Analysis

BMO’s rerating looks like a classic multiple compression risk disguised as a quality re-rating: when a bank trades well above its long-run band, the market is no longer paying for earnings, it is paying for a narrative. The problem is that narrative-driven upside in banks tends to be fragile because the earnings path is still dominated by credit costs, funding mix, and the slope of the North American growth curve. If the U.S.-centric growth thesis slows even modestly, the valuation can revert faster than fundamentals change.

The second-order issue is that integration optimism often pulls forward 12-24 months of good news into the stock price, leaving less room for error. In a high-multiple bank, any disappointment in operating leverage, deposit retention, or loan growth can compress the multiple by 1-2 turns without a major EPS miss. That asymmetry matters because the downside from 17x back toward a more normal 11-12x is materially larger than the upside from another incremental quarter of execution.

Consensus appears to be underpricing macro sensitivity: banks with U.S. exposure benefit on the way up, but they also inherit more credit beta, more rate-path uncertainty, and more consumer stress if growth decelerates. The market may also be ignoring that post-deal synergies are increasingly a basis of defense rather than a source of surprise, which usually means the next catalyst is not acceleration but normalization. In that regime, the right question is not whether BMO is improving, but whether the current multiple already assumes a permanently better business mix that may prove cyclical.

Key Decisions for Investors

• Reduce/avoid initiating fresh longs in BMO near the current multiple; the risk/reward is poor with ~1-2 turns of downside multiple compression possible over the next 3-6 months if growth expectations fade.
• Pair trade: short BMO / long a lower-multiple Canadian bank with more visible domestic deposit stability for the next 1-2 quarters; this expresses a valuation mean-reversion view while reducing sector beta.
• For existing holders, consider buying 3-6 month put spreads on BMO to hedge a rerating unwind; target protection against a move back toward the historical 11-12x P/E band.
• If you want exposure to the U.S. growth thesis, wait for a post-earnings reset or a 10-15% pullback before adding; the entry point matters more than the thesis at this valuation.
• Trim into strength rather than on weakness: if BMO sustains the current premium after the next two earnings prints, use that window to de-risk, since the best-case scenario is already largely capitalized.